Here's how you can complete the quests in Epic Minigames to get a Rune and Key during the Halloween Spotlight event on Roblox ...

Lily Allen's new album 'West End Girl' has fans questioning if the singer dropped hints about David Harbour's alleged affair ...

Launch the Destroy game on Roblox. Click on the Codes button on the right side of your screen. Type a working code in the pop ...

Lizzy Lawrence leads STAT’s coverage of the Food and Drug Administration. She was previously a medical devices reporter. You can reach Lizzy on Signal at lizzylaw.53. WASHINGTON — Peter Marks, the ...

RIVALS is an intense shooter game on the Roblox platform, offering a variety of game modes like 1v1, 2v2, and so on, going up to 5v5 team battles with a robust FPS experience. The game also offers a ...

Dominik Bošnjak is a freelance writer from Croatia. He has been writing about games for as long as he can remember and is sure he began doing so professionally in 2010 or thereabouts. If he was forced ...

Jonathan Wosen is STAT’s West Coast biotech & life sciences reporter. You can reach Jonathan on Signal at jwosen.27. SAN DIEGO — Riding high on the success of its blockbuster weight loss drug, Eli ...

HOUSTON — Seven months after Eli Lilly and Co. (NYSE: LLY) first began soliciting sites for major manufacturing proposals, Houston’s combination of tax incentives, real estate and inherent strength ...

Eli Lilly said it received marketing authorization from the European Commission for Kisunla, a treatment for early symptomatic Alzheimer's disease. Kisunla showed in a phase 3 trial that it can ...

Eli Lilly received approval from the Food and Drug Administration for Inluriyo, a treatment for adults with certain mutated or metastatic breast cancers. The FDA approved Inluriyo based on data from a ...

Eli Lilly & Co. halted a study of an experimental drug designed to prevent obesity patients from losing too much muscle, citing strategic business reasons it didn’t disclose. Lilly closed the trial on ...

Eli Lilly has pulled the plug on a phase 2b obesity trial before enrolling a single patient, citing “strategic business reasons.” The study was designed to test bimagrumab, an asset Lilly acquired in ...